Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Prostate Cancer
Interventions: DRUG: Abiraterone acetate|DRUG: Prednisolone|DRUG: Goserelin
Sponsor: West China Hospital